MedMira Inc Total Assets

Latest as of April 2026: CA$3.40 Million CAD ≈ $2.46 Million USD

MedMira Inc total assets. Based on the latest financial reports, MedMira Inc (MIR) holds total assets worth CA$3.40 Million CAD (≈ $2.46 Million USD) as of April 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MedMira Inc stock valuation for the company's overall valuation and market capitalisation.

Total Assets of MedMira Inc (2000–2025)

Total assets of MedMira Inc from 2000 to 2025. This chart illustrates how MedMira Inc's total assets have evolved over time, based on quarterly financial data. See MIR share price today for real-time trading data and today's change.

MedMira Inc - Asset Composition Analysis

MedMira Inc Total Assets Breakdown (July 2025)

MedMira Inc total assets breakdown as of July 2025. MedMira Inc's total assets of CA$3.40 Million consist of 43.4% current assets and 56.6% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	0.4%
Accounts Receivable	CA$1.32 Million	35.8%
Inventory	CA$206.07K	5.6%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$2.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how MedMira Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MedMira Inc (MIR) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: MedMira Inc's current assets represent 43.4% of total assets in 2025, a decrease from 74.3% in 2000.
Cash Position: Cash and equivalents constituted 0.4% of total assets in 2025, up from -164.4% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is accounts receivable at 35.8% of total assets.

MedMira Inc Competitors by Total Assets

Key competitors of MedMira Inc based on total assets are shown below.

Company	Country	Total Assets
CSL LTD SPON.ADR 2 F:CSJA	Germany	€38.45 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	China	CN¥8.59 Billion
Xiamen Amoytop Biotech Co Ltd SHG:688278	China	CN¥3.21 Billion
Neuren Pharmaceuticals Ltd AU:NEU	Australia	AU$331.25 Million
PHARVARIS N.V. EO -12 F:9EN	Germany	€301.45 Million
NANOBIOTIX S.A. SP.ADR F:5NRA	Germany	€67.76 Million
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	China	CN¥3.82 Billion

MedMira Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.06	0.07	0.09
Quick Ratio	0.05	0.06	0.08
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-23.85 Million	CA$-20.09 Million	CA$-15.84 Million

MedMira Inc - Advanced Valuation Insights

This section examines the relationship between MedMira Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	-
Latest Market Cap to Assets Ratio	6.89
Asset Growth Rate (YoY)	-39.3%
Total Assets	CA$3.68 Million
Market Capitalization	$25.38 Million USD

Valuation Analysis

Premium Asset Valuation: The market values MedMira Inc's assets at a significant premium (6.89x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: MedMira Inc's assets decreased by 39.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for MedMira Inc (2000–2025)

The table below shows the annual total assets of MedMira Inc from 2000 to 2025.

Year	Total Assets	Change
2025-07-31	CA$3.68 Million ≈ $2.66 Million	-39.34%
2024-07-31	CA$6.07 Million ≈ $4.39 Million	+66.21%
2023-07-31	CA$3.65 Million ≈ $2.64 Million	-4.64%
2022-07-31	CA$3.83 Million ≈ $2.77 Million	-1.56%
2021-07-31	CA$3.89 Million ≈ $2.81 Million	+14.55%
2020-07-31	CA$3.40 Million ≈ $2.46 Million	+1244.88%
2019-07-31	CA$252.52K ≈ $182.67K	-16.08%
2018-07-31	CA$300.91K ≈ $217.68K	-55.33%
2017-07-31	CA$673.71K ≈ $487.35K	-22.55%
2016-07-31	CA$869.90K ≈ $629.28K	-51.23%
2015-07-31	CA$1.78 Million ≈ $1.29 Million	-3.16%
2014-07-31	CA$1.84 Million ≈ $1.33 Million	+57.86%
2013-07-31	CA$1.17 Million ≈ $844.08K	-60.72%
2012-07-31	CA$2.97 Million ≈ $2.15 Million	+99.06%
2011-07-31	CA$1.49 Million ≈ $1.08 Million	+162.62%
2010-07-31	CA$568.18K ≈ $411.01K	+8.55%
2009-07-31	CA$523.41K ≈ $378.63K	-37.18%
2008-07-31	CA$833.19K ≈ $602.71K	-70.91%
2007-07-31	CA$2.86 Million ≈ $2.07 Million	-28.54%
2006-07-31	CA$4.01 Million ≈ $2.90 Million	+180.64%
2005-07-31	CA$1.43 Million ≈ $1.03 Million	-15.67%
2004-07-31	CA$1.69 Million ≈ $1.23 Million	-28.26%
2003-07-31	CA$2.36 Million ≈ $1.71 Million	-29.80%
2002-07-31	CA$3.36 Million ≈ $2.43 Million	+11.05%
2001-07-31	CA$3.03 Million ≈ $2.19 Million	-16.26%
2000-07-31	CA$3.62 Million ≈ $2.62 Million	--

About MedMira Inc

V:MIR Canada Biotechnology

Market Cap

$25.38 Million

CA$35.09 Million CAD

Market Cap Rank

#24174 Global

#902 in Canada

Share Price

CA$0.05

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.08

All Time High

CA$0.70